Position in ONCY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,400
+$5,310 QoQ
Shares Held
12,000
+71.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 74 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ONCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $1,028,190 across 22 Biotechnology names. ONCY ranks #9 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,091 | $680,282 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
191 | $94,875 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
161 | $86,448 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 5 | VTVT |
vTv Therapeutics Inc.
|
980 | $36,897 | |
| 6 | MRNA |
Moderna, Inc.
|
329 | $23,039 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
200 | $16,302 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
350 | $13,653 |
All Filings in ONCY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,400 | 12,000 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $6,090 | 7,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $9,800 | 7,000 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $5,390 | 7,000 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,217 | 5,850 | Shares | Sole | 2025-04-25 | |
| No filing history on record for this holder in this stock. | ||||||